Resveratrol improves diabetes‐induced cognitive dysfunction in part through the miR‐146a‐5p/TXNIP axis

Abstract

AbstractResveratrol (RSV) has been shown to have a neuroprotective effect in various central nervous system disorders, although the role of RSV in diabetes‐induced cognitive dysfunction is still not fully elucidated. Here, we investigated whether RSV improved diabetes‐related cognitive dysfunction in vivo and in vitro. We induced a rat diabetic model with a high‐fat and high‐sucrose diet followed by intraperitoneal injection of streptozotocin and a diabetic neuron cell model by stimulation with high levels of glucose. We observed that RSV improved impairment in spatial learning and memory in the Morris water maze test (MWM) and novel object recognition test (ORT) in diabetic rats. RSV reversed the reduced miR‐146a‐5p and upregulated thioredoxin‐interacting protein (TXNIP) and inhibited the diabetes‐induced increase in interleukin (IL)‐1β and tumor necrosis factor (TNF)‐α levels in vivo and in vitro. RSV also inhibited diabetes‐induced endoplasmic reticulum stress (ESR) by reducing ESR‐related protein expression in vivo and in vitro. Moreover, inhibition of miR‐146a‐5p partially abolished the protective effects of RSV in HG‐treated primary neurons. Additionally, we used starBase to predict that miR‐146a‐5p interacts with TXNIP, which we then verified using a luciferase reporter gene assay. We further observed that miR‐146a‐5p regulates the mRNA and protein expression of TXNIP in vitro, indicating that the miR‐146a‐5p/TXNIP axis is involved in the regulation of cognitive dysfunction in a rat diabetic model. Collectively, these results demonstrate that RSV plays a neuroprotective role in diabetes‐associated cognitive dysfunction at least in part through regulation of the miR‐146a‐5p/TXNIP axis.